Abstract
Patients admitted to intensive care units (ICUs) represent 8 to 15% of overall hospital population [1]. A frequent problem related to ICU stay is the relative high incidence of infections, rates of which are higher than 40% as reported in some prevalence studies [2, 3]. This percentage is 5–10 times higher when compared with the infections in patients admitted in the normal wards; furthermore, in some hospitals of United States, recurrence of infections in ICUs represents more than 20% of overall nosocomial infections [4].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Weinstein RA (1991) Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 91[Suppl 3B]: 179S–184S
Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infections in intensive care units in Europe. JAMA 274: 639–644
de León-Rosales SP, Molinar-Ramos F, Domínguez-Cherit G et al (2000) Prevalence of infections in intensive care units in Mexico: a multicenter study. Crit Care Med 28: 1316–1321
Craven DE, Kunches LM, Lichtemberg DA et al (1988) Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 148: 1161–1168
NNIS System Report (1997) National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986–April 1997, issued May 1997. Am J Infect Control 25: 477–487
Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91[Suppl 3B]: 72S–75S
Bergogne-Bérézin E (1999) Current guidelines for the treatment and prevention of nosocomial infections. Drugs 58: 51–67
D’Amico R, Pifferi S, Legnetti C et al (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. Br Med Journal 316: 1275–1285
Trilla A (1994) Epidemiology of nosocomial infections in adult intensive care units. Int Care Med 20: S1–S4
Legras A, Malvy D, Quinioux AI et al (1998) Nosocomial infections: prospective survey of incidence in five French intensive care units. Int Care Med 24: 1040–1046
Gaynes RP, Culver DH, Emori TG et al (1991) The National Nosocomial Infections Surveillance System: plans for the 1990s and beyond. Am J Med 91[Suppl 3B]: 116S–120S
Richards MJ, Edwards JR, Culver DH et al (1999) Nosocomial infections in medical intensive care units in the United States. Crit Care Med 27: 887–892
Weber DJ, Raash R, Rutala WA (1999) Nosocomial infections in the ICU: the growing importance of antibiotic resistant pathogens. Chest 115: 34S–41S
Wallace WC, Cinat M, Gornik WB et al (1999) Nosocomial infections in the surgical intensive care unit: a difference between trauma and surgical patients. Am Surg 65: 987–990
Garner JS, Jarvis WR, Emori TG et al (1988) CDC definitions for nosocomial infections. Am J Infect Control 16: 128–140
Potgieter PD, Hammond JM (1992) Etiology and diagnosis of pneumonia requiring ICU admission. Chest 101: 199–203
Mosconi P, Langer M, Cigada M et al (1991) Epidemiology and risk factors of pneumonia in critically ill patients. Eur J Epidemiol 7: 320–327
Antonelli M, Moro ML, D’Errico RR et al (1996) Early and late onset bacteremia have a different risk factors in trauma patients. Int Care Med 22: 735–741
Troullet JL, Chastre J, Vuagnat A et al (1998) Ventilator associated pneumonia caused by potentially drug resistant bacteria. Am J Respir Crit Care Med 157: 531–539
Van Saene HKF, Damjanovic V, Murray AE, de la Cal MA (1996) How to classify infections in intensive care units — the carrier state, a criterion whose time has come? J Hosp Infect 33: 1–12
De la Cal MA, Cerdà E, Garcia-Hierro P (1998) Classification of micro-organisms according to their pathogenicity. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 9-16
Silvestri L, Monti Bragadin C, Milanese M et al (1999) Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 42: 125–133
Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al (1997) Candidaemia in non-neutropenic critically ill patients: analysis of prognosis factors and assessment of systemic antifungal therapy. Int Care Med 23: 23–30
Petri MG, König J, Moeke HP et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Int Care Med 23: 317–325
Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758
Vincent JL, Anaissie E, Bruining H et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Int Care Med 24: 206–216
Flanagan PG, Barnes RA (1998) Fungal infection in the intensive care unit. J Hosp Infect 38: 163–177
Johnson EW, Warnok DW (1995) Azole drug resistance in yeasts. J Antimicrob Chemother 36: 751–755
Archibald L, Phillips L, Monnet D et al (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24: 211–215
Livermore DM (2000) Epidemiology of antibiotic resistance. Int Care Med 26: S14–S21
Huang AH, Yan JJ, Wu JJ (2000) Rapid dissemination of Staphylococcus aureus with classic oxacillin resistance phenotype at a new university hospital. J Hosp Infect 44: 309–315
van Saene, de la Cal MA, Petros AJ et al (1998) Management of antimicrobial resistance in the intensive care unit. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 323-340
Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of multiresistant Gram-negative bacilli. Ann Intern Med 110: 873–881
Moellering RC (1998) The specter of glycopeptide resistance: current trends and future considerations. Am J Med 104: 3S–6S
Goldman DA, Weinstein RA, Wenzel RP et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial resistant microorganisms in hospitals. JAMA 275: 234–240
Moro ML, Jepsen OB (1996) Infection control practices in intensive care units of 14 European countries. Int Care Med 22: 872–879
Shlaes DM, Gerding DN, John JF et al (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25: 584–599
Souweine B, Traore O, Aublet-Cuvelier B et al (2000) Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 45: 107–116
Kollef MH (1999) The prevention of ventilator associated pneumonia. N Engl J Med 340: 627–634
Rahman M, Chattopadhyay B (2000) Handwashing: unanswered questions and compliance. J Hosp Infect 45: 249–250
Sax H, Pittet D (2000) Disinfectants that do. Curr Opin Infect Dis 13: 395–399
Flaherty JP, Weinstein RA (1996) Nosocomial infections caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 17: 236–248
O’Connel NH, Humphreys H (2000) Intensive care unit design and environmental factors in the acquisition of infection. J Hosp Infect 45: 255–262
Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem
Van Der Waaij D (1989) The ecology of human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 43: 69–87
Marshall JC, Christou NV, Meakins JL (1993) The gastrointestinal tract. The “undrained abscess” of multiple organ failure. Ann Surg 218: 111–119
Marshall JC (1999) Gastrointestinal flora and its alterations in critical illness. Curr Opin Crit Care 51: 119–125
Sganga G, Gangheri G, Castagneto M (1998) The gut: a central organ in the development of multiple organ system failure. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the Intensive Care Unit. Springer Verlag, pp 269-277
Feltis BA, Wells CL (2000) Does microbial translocation play a role in critical illness? Curr Opin Crit Care 6: 117–122
O’Boyle CJ, MacFie J, Mitchell CJ et al (1998) Microbiology of bacterial translocation in humans. Gut 42: 29–35
Edlund C, Hedberg M, Nord CE (2000) Ecological impact of beta-lactam treatment on normal human intestinal flora. In: Vincent JL (ed) 2000 Yearbook of Intensive Care and Emergency Medicine. Springer Verlag, pp 111-122
Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients: a systematic review of evidence. Arch Surg 134: 170–176
Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF (1996) Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Int Care Med 22: 699–706
Fowler RA, Cheung AM, Marshall JC (1999) Selective decontamination of the digestive tract in the critically ill patients. Int Care Med 25: 1323–1326
Rocha RA, Martin MJ, Pita S et al (1992) Prevention of nosocomial infections in critically ill patients by selective decontamination of the digestive tract. A randomised double blind placebo-controlled study. Int Care Med 18: 398–404
Garcia MS, Galoche JAC, Diaz JL et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158: 908–916
Coello R, Glynn JR, Gaspar C et al (1997) Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 37: 39–46
Dacre J, Emmerson AM, Jenner EA (1986) Gentamicin-methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect 7: 130–136
Wenzel RP, Nettleman MD, Jones RN, Pfaller MA (1991) Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 91[Suppl 3B]: 221S–227S
Cookson BD (1990) Mupirocin resistance in Staphylococci. J Antimicrob Chemother 25: 497–503
Miller MA, Dascal A, Portnoy J, Mendelson J (1996) Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17: 811–813
Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA 265: 2704–2710
Hill RLR, Casewell MW (2000) The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 45: 198–205
Viviani M, Berlot G, Dezzoni R et al (2000) The impact of topical vancomycin on MRSA gut carriage and infections in ICU patients. Int Care Med 26: S292
Silvestri L, Mannucci F, van Saene HKF (2000) Selective decontamination of the digestive tract: a life saver. J Hosp Infect 45: 185–190
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Viviani, M., Berlot, G., Gullo, A. (2001). Epidemiology of Infections in ICUs: Where Are We?. In: Baue, A.E., Berlot, G., Gullo, A., Vincent, JL. (eds) Sepsis and Organ Dysfunction. Springer, Milano. https://doi.org/10.1007/978-88-470-2229-4_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-2229-4_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0137-4
Online ISBN: 978-88-470-2229-4
eBook Packages: Springer Book Archive